Sentinel lymph node biopsy after neoadjuvant treatment of breast cancer using blue dye, radioisotope, and indocyanine green: Prospective cohort study

BACKGROUND: The breast cancer treatment paradigm has shifted to neoadjuvant treatment. There are many advantages to neoadjuvant treatment, such as tumor downsizing, in vivo tumor biology testing, treating micrometastasis, and achieving complete pathological response (a surrogate marker for overall s...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Med Surg (Lond)
Autors principals: Chirappapha, Prakasit, Chatmongkonwat, Tanet, Lertsithichai, Panuwat, Pipatsakulroj, Wiriya, Sritara, Chanika, Sukarayothin, Thongchai
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2020
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7548931/
https://ncbi.nlm.nih.gov/pubmed/33072308
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amsu.2020.09.030
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars